Where acceptance is all there is
I have received a lot of interest from others on here in my involvement with the Xeljanz trials at Yale.
I thought it would be nice for everyone if I documented my progress on here.
Xeljanz is a Jak3 inhibitor and is believed to work with alopecia by turning off the distress signal relayed by the hair follicle to the attacking immune system which is the cause of the hairs falling out. Xeljanz comes in a strength of 5mg per pill and a full box contains 60 tablets. The recommended dosage for arthritis is 1 tablet in the morning and another in the evening each day.
The trial is set in a series of stages and there are requirements before participating. These include monthly visits and blood tests every 2 weeks. Dr Brett King is absolutely fantastic and is an inspiration to me. His positivity and enthusiasm gives me the much needed hope I have craved for over a decade. I have been put on a low dose to start with which is 1 tablet every other day. My dosage has now been increased to 1 tablet every day and next month it could be increased to 2 tablets per day depending on the results.
I have completed my first month and have already noticed my alopecia has stabilised . I have not lost any existing hairs. In addition to this I have seen little hairs growing in my chest area as well as eyebrows. Fingers crossed! To date, I have experienced no side effects.
I have a treatment for alopecia if anyone interested to try contact me 00962796825349
What's your treatment?
It's a cream . You can contact me whatsapp for more info i had alopecia universalis for 15 years and this is thr only thing worked for me .
I don't make it I just provided for people to try it from a pharmacist in my country
Smells like a scam
What's your country code ???
I honestly feel that too
Jordan my friend am not scamming or selling I just provided for people who needs it that's it.
Not everyone tries to help is a scammmer .
Specialy that I used to suffer from it
At Yale the Xeljanz trial is ending next year. It is highly likely another trial would be started if all the results are great.
I agree. Columbia University is also looking to do a study on tofacitinib (Xeljanz) starting this fall. Hopefully they can get a topical going as well...that would at least help a lot of AA patients and reduce the drug exposure/ risk.
For FDA traction, larger studies will be needed. But all is very positive.
What ever became of the study on abatacept for AA, tried to research this and it looks like its been withdrawn?
Hi, would you mind sharing if you experienced any success on Xeljanz?